| |
| |
|
| Insider
Information: |
Alton Gregg H |
| Relationship: |
Director |
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
61,846 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,756,942 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
61,846 |
|
|
| Total
Value |
$3,756,942 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
Chief Patient Officer |
2019-02-15 |
58,046 |
2018-02-20 |
0 |
Premium* |
|
|
Novavax Inc |
NVAX |
Director |
2023-06-10 |
3,800 |
2022-06-17 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
360 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 11 of 15
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2012-07-02 |
4 |
AS |
$51.27 |
$410,130 |
D/D |
(8,000) |
39,790 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2008-07-01 |
4 |
S |
$51.33 |
$363,059 |
D/D |
(7,000) |
55,560 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2012-05-01 |
4 |
S |
$51.69 |
$413,528 |
D/D |
(8,000) |
41,057 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2008-05-01 |
4 |
S |
$51.70 |
$366,920 |
D/D |
(7,000) |
54,716 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2008-04-01 |
4 |
S |
$51.85 |
$366,147 |
D/D |
(7,000) |
54,716 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2012-05-02 |
4 |
S |
$52.00 |
$208,000 |
D/D |
(4,000) |
41,057 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2012-07-03 |
4 |
AS |
$52.00 |
$416,000 |
D/D |
(8,000) |
39,790 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2009-02-03 |
4 |
A |
$52.01 |
$119,623 |
D/D |
2,300 |
54,696 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2013-07-01 |
4 |
AS |
$52.04 |
$1,562,628 |
D/D |
(30,000) |
55,938 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2013-06-03 |
4 |
AS |
$52.10 |
$1,583,121 |
D/D |
(30,000) |
59,938 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2008-08-01 |
4 |
S |
$53.14 |
$375,001 |
D/D |
(7,000) |
55,560 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2012-04-19 |
4 |
S |
$53.98 |
$4,210,393 |
D/D |
(78,000) |
42,057 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2005-11-21 |
4 |
S |
$54.00 |
$972,799 |
D/D |
(18,010) |
19,354 |
|
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2008-06-02 |
4 |
S |
$54.05 |
$382,093 |
D/D |
(7,000) |
54,716 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2012-08-01 |
4 |
AS |
$54.08 |
$649,000 |
D/D |
(12,000) |
38,790 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2012-07-27 |
4 |
AS |
$55.03 |
$3,851,911 |
D/D |
(70,000) |
39,790 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
Chief Patient Officer |
• • – |
2019-02-15 |
4 |
A |
$57.45 |
$18,959 |
D/D |
330 |
58,046 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2012-09-04 |
4 |
AS |
$57.50 |
$1,265,062 |
D/D |
(22,000) |
37,790 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2012-08-02 |
4 |
AS |
$57.95 |
$3,476,850 |
D/D |
(60,000) |
38,790 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP Comm&Acs ALA, Corp&Med Aff |
• • – |
2017-02-15 |
4 |
A |
$59.33 |
$18,689 |
D/D |
315 |
123,279 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2013-09-03 |
4 |
AS |
$60.97 |
$1,829,667 |
D/D |
(30,000) |
46,938 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2013-08-01 |
4 |
AS |
$61.48 |
$1,844,836 |
D/D |
(30,000) |
51,938 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
SVP, General Counsel |
• – – |
2006-07-25 |
4 |
S |
$62.00 |
$310,000 |
D/D |
(5,000) |
32,036 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP,Corporate &Medical Affairs |
• • – |
2018-02-15 |
4 |
A |
$62.35 |
$21,198 |
D/D |
340 |
38,078 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, Corp & Med Affairs |
• – – |
2013-10-01 |
4 |
AS |
$62.75 |
$1,882,549 |
D/D |
(30,000) |
42,938 |
0 |
- |
|
360 Records found
|
|
Page 11 of 15 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
